DTL
MCRB icon

Dynamic Technology Lab’s Seres Therapeutics MCRB Stock Holding History

Dynamic Technology Lab’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,360
Closed -$208K – 1259
2023
Q3 		$208K Buy
4,360
+2,178
+100% +$166K 0.02% 778
2023
Q2 		$209K Buy
+2,182
New +$237K 0.03% 817
2022
Q1 		– Sell
-1,080
Closed -$180K – 1341
2021
Q4 		$180K Buy
+1,080
New +$172K 0.02% 979
2020
Q3 		– Sell
-900
Closed -$86K – 1202
2020
Q2 		$86K Buy
+900
New +$79K 0.01% 898

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's MCRB Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 4,360 shares — an estimated $208K sold.

Dynamic Technology Lab first reported a position in MCRB in Q2 2020 and held it in 4 quarters. The position peaked at $209K in Q2 2023. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 4,360 Seres Therapeutics shares in Q4 2023, an estimated $208K.
  • Dynamic Technology Lab first reported a position in Seres Therapeutics in Q2 2020 and held it in 4 quarters.
  • Dynamic Technology Lab's Seres Therapeutics position peaked at $209K in Q2 2023.
  • 102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.